Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
IDNA vs LOGSX
Shared holdings
5
IDNA covered by LOGSX
15.10%
LOGSX covered by IDNA
15.10%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
IDNA (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| BlackRock Cash Funds: Institutional, SL Agency Shares | 14.21% | |
| MODERNA INC | 5.05% | |
| Bayer Aktiengesellschaft | 4.33% | |
| REVOLUTION MEDICINES INC | 3.86% | |
| TAKEDA PHARMACEU | 3.80% | |
| BIONTECH SE ADR | 3.75% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 3.73% | |
| IPSEN | 3.65% | |
| MERCK & CO | 3.51% | |
| GSK PLC | 3.41% | |
| REGENERON PHARMACEUTICALS INC | 3.27% | |
| VERTEX PHARMACEUTICALS INC | 3.27% | |
| GENMAB AS | 3.26% | |
| INCYTE CORP | 3.10% | |
| Sanofi SA | 3.02% | |
| EXELIXIS INC | 2.96% | |
| ARCELLX INC | 2.75% | |
| IDEAYA BIOSCIENCES | 2.51% | |
| CARIS LIFE SCIENCES INC | 2.49% | |
| TWIST BIOSCIENCE CORP | 2.23% | |
| IMMUNITYBIO INC | 1.93% | |
| ONO PHARMA | 1.66% | |
| ARCUS BIOSCIENCES INC | 1.47% | |
| CRISPR Therapeutics A.G. Series A | 1.44% | |
| NOVAVAX INC | 1.22% | |
| NUVATION BIO INC | 1.17% | |
| CORVUS PHARMACEUTICALS INC | 1.11% | |
| IOVANCE BIOTHERAPEUTICS INC | 0.79% | |
| AbCellera Biologics Inc COM | 0.78% | |
| GENFLEET THERAPEUTICS SHANGHAI INC | 0.71% | |
| JANUX THERAPEUTICS INC | 0.69% | |
| CYTOMX THERAPEUTICS INC | 0.68% | |
| VIR BIOTECHNOLOGY INC | 0.65% | |
| KURA ONCOLOGY INC | 0.64% | |
| VALNEVA SE | 0.62% | |
| ABCLON INC | 0.62% | |
| RIGEL PHARMACEUTICALS INC | 0.57% | |
| PACIFIC BIOSCIENES OF CALI INC | 0.57% | |
| SUNSHINE LAKE PHARMA CO LTD | 0.54% | |
| ALVOTECH SA | 0.53% | |
| PERSONALIS INC | 0.46% | |
| INTELLIA THERAPEUTICS INC | 0.46% | |
| OCUGEN INC | 0.42% | |
| VERASTEM INC | 0.37% | |
| GINKGO BIOWORKS HOLDINGS INC | 0.35% | |
| SHANGHAI HENLIUS BIOTECH INC H | 0.32% | |
| DESIGN THERAPEUTICS INC | 0.30% | |
| XENCOR INC | 0.26% | |
| GUANGZHOU INNOGEN PHARMACEUTICAL GROUP CO LTD | 0.24% | |
| PRIME MEDICINE INC | 0.11% |
LOGSX (April 30, 2026)
| Security | Weight | |
|---|---|---|
| UNITED THERAPEUTICS CORP DEL | 6.10% | |
| CARDINAL HEALTH INC | 5.31% | |
| JAZZ PHARMACEUTI | 5.01% | |
| Novartis AG | 4.78% | |
| CENCORA INC | 4.77% | |
| AMGEN INC | 4.72% | |
| Mount Vernon Liquid Assets Portfolio, LLC | 4.67% | |
| MCKESSON CORP | 4.67% | |
| EXELIXIS INC | 4.49% | |
| REGENERON PHARMACEUTICALS INC | 4.44% | |
| LANTHEUS HOLDING | 4.30% | |
| JOHNSON&JOHNSON | 3.66% | |
| BRISTOL-MYERS SQUIBB CO | 3.50% | |
| THE CIGNA GROUP | 3.39% | |
| GILEAD SCIENCES INC | 3.37% | |
| NATL HEALTHCARE | 3.21% | |
| VERTEX PHARMACEUTICALS INC | 3.15% | |
| INTUITIVE SURGICAL INC | 3.10% | |
| US ULTRA BOND CBT Sep25 | 3.03% | |
| MEDPACE HOLDINGS INC | 2.90% | |
| MERCK & CO | 2.87% | |
| INCYTE CORP | 2.85% | |
| STRYKER CORP | 2.06% | |
| LABCORP HOLDINGS INC | 2.05% | |
| MEDTRONIC PLC | 1.93% | |
| LILLY ELI and CO | 1.75% | |
| OPTION | 1.62% | |
| ELEVANCE HEALTH INC | 1.18% | |
| ENSIGN GROUP INC | 1.13% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.